New user, registration is FREE Sign In  
Women & Wine Wednesdays - Happy New Year!
We are excited to have MIT alumnae Dr. Anita Goel, MD, PhD, CEO and Co-Founder of Nanobiosym, and her sister and Co-Founder, Lisa Goel, MBA '22, join us for a Fireside Chat to share the fascinating story of their company, Nanobiosym.

Join us for the 50th WWW. Learn more about this adventurous journey from Stanford, Harvard, and MIT and breakthrough innovation winning multiple awards including 3 DARPA Breakthrough Awards, 2 USAID Grand Challenge Awards, and the Galactic Challenge Award in conjunction with NASA & Elon Musk's SpaceX, and multiple DOD & US Government Contracts. Nanobiosym also won the 1st XPRIZE to ever be awarded in healthcare (inspired by the Star Trek TriCorder) and received multiple medical device related regulatory approvals from FDA, ISO13485, CLIA, CAP, established their own Precision NanoManufacturing facility in Massachusetts and their own CLIA and CAP certified Clinical Testing Lab.

Also learn about their FDA EUA Authorized Nano Test for COVID and other future high precision tests and services in their pipeline and the Company's mission to empower anyone anywhere anytime with information about what is happening inside their own body. Nanobiosym was founded to create breakthrough scientific insights and transformational technologies that emerge from the convergence of physics, nanotechnology, and biomedicine.

Dr. Anita Goel, MD, PHD, Physicist & Physician; Chairman and CEO, Nanobiosym is a world-renowned expert and global entrepreneur in the emerging field of Nanobiophysics. As the Chairman and CEO of Nanobiosym Diagnostics (NBSDx), she oversees all product design, engineering, clinical trials, regulatory approvals and manufacturing of the company's breakthrough technologies, such as the X-PRIZE winning Gene-RADAR® and its “apps” for personalized precision medicine, digital health and global health security. In 2020, Barclay’s Bank and the Unreasonable Group selected Nanobiosym Dx amongst the “World’s Top 10 Companies solving the Global COVID Crisis” and Scientific American featured her work on how mobile precision testing for COVID could safely re-open the US and Global Economy. The 2019 “Davos in the Desert” Conference featured Dr. Goel and Nanobiosym as one of the 12 most promising frontier technology companies that will shape “What’s Next for Global Business.

She was named as one of the World’s “Top 35 science and technology innovators” by MIT Technology Review and one of the "World's Most Influential Visionaries in Biotech" by Scientific American.Dr. Goel holds a Ph.D. and M.A. in Physics from Harvard University, an MD from the Harvard-MIT Joint Division of Health Sciences and Technology (HST) at Harvard Medical School and a BS in Physics with Honors & Distinction from Stanford University.

Lisa Goel is Vice President of Technology, Operations & Business Innovations and is a member of the founding team of Nanobiosym since 2002. She currently handles Technology & Business Operations Strategy. She received her BS in Biomedical engineering from Boston University, MS in Biomedical Engineering from Tufts University, and her MBA from MIT Sloan ('22).  

Wednesday, January 4, 2023

6:00 p.m - 9:00 p.m. ET

The Ritz Carlton, Boston, MA 02210


We look forward to greeting familiar faces and making new friends with talented women professionals – alumnae & friends.  We hope to see you as we strengthen and expand our network of alumnae and professional women. Join us to ring in 2023 at the Ritz!! 

For more information please contact Tina Kruczynski at, or Audrey Daum SM ’88 at

Our Women's Events Volunteer Committee includes:

  • Audrey Daum, SM '88, SBAA Board Co-Chair Women’s Events, Chair, Women and Wine Wednesdays & Senior Vice President – Investments, Moors & Cabot,
  • Sun Altbach, MBA '11, CEO & President, PIC Therapeutics,
  • Monica Kothari, MBA '19, Regions Lead, Campus Strategy, Capital One,
  • Dr. Irena Lucifredi, PhD '05, President, SOFAR Acoustics, LLC,
  • Katie Manty, SM '02, VP, Omnichannel Strategy,
  • Suzanne Oakley, MBA '95, Owner, New England CFO Strategies,
  • Tina Kruczynski, Program Manager, MITSBAA,
COVID-19 POLICY: MITSBAA is adhering to MIT and the CDC Guidelines. All registrants must self-attest to (a) full vaccination 14 days prior to this event, and (b) participation is voluntary and attendees are responsible for their own protection against Covid-19.

We will provide hand sanitizer and masks to all attendees.

Event Information
Wednesday, Jan 4 2023 at 6:00pm - 9:00pm [ iCal ]
The Ritz Carleton
10 Avery Street
Boston, MA 02111
Boston Skyline Panorama courtesy Nietnagel © 2010
© Copyright MIT Sloan Boston Alumni Association, ALL RIGHTS RESERVED.

Alumni Development Software